Evaluation of trends in prescription drugs for overactive bladder in Japanese patients

Int J Urol. 2023 Mar;30(3):331-333. doi: 10.1111/iju.15117. Epub 2022 Dec 7.

Authors

Motofumi Suzuki¹, Masahiro Yamamoto¹, Taichi Shiratori¹, Akihiro Naito¹, Masaki Nakamura²

Affiliations

¹ Department of Urology, Tokyo Metropolitan Bokutoh Hospital, Sumida-ku, Tokyo, Japan.
² Department of Urology, NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, Japan.

PMID: 36479727
DOI: 10.1111/iju.15117

No abstract available

MeSH terms

East Asian People
Humans
Muscarinic Antagonists
Prescription Drugs*
Urinary Bladder, Overactive*

Substances

Prescription Drugs
Muscarinic Antagonists

Grants and funding

Tokyo Metropolitan Hospital Organization